Background: Anemia in pregnancy is common and linked to postpartum hemorrhage in terms of uterine atony. The more severe the anemia, the more likely the greater blood loss and adverse outcome. The aim of this study was to examine the association between anemic women at labor and postpartum hemorrhage (PPH) during emergency cesarean delivery and to assess the hemoglobin (Hb) values at which the emergency hysterectomy is needed. Methods and patients: A cross-sectional study was carried out between (Aug. 1st 2012 and Jul. 30th 2013) at Al Thawra General hospital. Fifty-three cases were included in the study. Results: Postpartum hemorrhage was developed in 53 women (29.1%). Out of 53 women, 21 cases (39.6%) had severe uterine atony and required emergency hysterectomy and the remaining 32 cases (60.37%) responded to the conservative measures (p 0.03). Most of the hysterectomized women 80.75% (17/21) had Hb levels 6 7 versus 12.5% of the nonhysterectomized patients [OR 29.75;; p < 0.01]. There was a strong correlation between low Hb levels and blood loss [r = À.619; p < 0.00]. Conclusion: Our study supports the association between anemia (Hb < 10) and the risk of PPH. We also provide evidence of the association between severe anemia and emergency hysterectomy. ª 2014 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
The data about the safety of vaginal birth after caesarean section are conflicting. This study in a referral hospital in Sana'a, Yemen investigated the outcome of vaginal birth after caesarean section in 357 women who had one prior caesarean section and were admitted to hospital at term with spontaneous onset of labour. A control group (n = 155) was matched from women without previous caesarean section. The success rate of vaginal birth after caesarean section was 311/357 (87.1%). The mean duration of the first and second stages of labour were not significantly different in the study group (146.2 and 30.7 min respectively) compared with the control group (146.7 and 29.8 min). There were infrequent complications; only 1 woman (0.3%) had ruptured uterus and 3 women (1.0%) suffered uterine dehiscence. There was 1 stillbirth after the uterine rupture but no maternal deaths.
Background: Low birth weight (LBW) remains prevalent and represents a public health problem in developing countries. Objective(s): The aim of present study was to estimate the occurrence and risk factors of low birth weight in Sanaa', Yemen.
This is a prospective study conducted to examine the possible benefit of antibiotic prophylaxis in reducing the symptoms of threatened miscarriage as well as decreasing the rate of progression into spontaneous miscarriage in women with first trimester vaginal bleeding. This study was conducted at Al Thawra General Hospital over a year (from Jan. to Dec 2016). Ninety-two women with threatened miscarriage during the first trimester were included (case group) and compared to 90 pregnant women without vaginal bleeding with similar parity and gestational age. Amoxicillin-clavulanate drug was given for all cases of the study group during vaginal bleeding. Both groups were monitored up to 28 weeks gestational age. Among 92 women with threatened miscarriage, only three cases (3.2%) had spontaneous loss (P < 0.001). Vaginal bleeding was significantly relieved within 3 days of antibiotic administration (P < 0.00). Results of this study give evidence that antibiotic prophylaxis for women with threatened miscarriage reduces the amount and duration of vaginal bleeding, and decreases the rate of progression into spontaneous miscarriage.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.